Market research from the manufacturers of capecitabine indicates that the ... Obviously, the toxic events associated with chemotherapy (i.e. nausea, fatigue and, to an extent, vomiting, diarrhea ...

In the past 5–10 years there has been a growing trend for substituting conventional 5-fluorouracil with the oral prodrug of 5-fluorouracil, capecitabine, in chemotherapy regimens. This regimen ...

If chemotherapy has been recommended for you ... The FDA labels for 5-FU and capecitabine have been updated to read that patients should be informed about the availability of genetic testing.

Watch the video below about what happens when you have chemotherapy. It is almost 3 minutes long. Between 2 and 8 out of 100 people (2 to 8%) have low levels of an enzyme called dihydropyrimidine ...

In this randomized controlled trial, among patients with early-stage triple-negative breast cancer (TNBC), the addition of ...

Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease The ESPAC4 trial showed that adjuvant ...

Presurgical camrelizumab plus chemotherapy significantly improved responses versus chemotherapy alone in early or locally ...

Dr. Marla Lipsyc-Sharf reviews her recent session at the 2024 SABCS meeting, discussing biopsy approaches and treatment ...

During a Case-Based Roundtable® event, David H. Ilson, MD, PhD, discussed the outcomes of the CheckMate 649, CheckMate 648, ...

Chemotherapy treatment was strongly recommended ... test to determine the likelihood of a very rare adverse reaction to capecitabine known as dehydrogenase enzyme deficiency testing.

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Even when diagnosed early, triple-negative breast cancer ...